Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | XLRN | AMGN | GILD | VRTX | REGN |
Company | Acceleron Pharma | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 179.85 | 274.18 | 65.32 | 392.81 | 889.41 |
High | 179.85 | 279.84 | 65.89 | 406.95 | 913.21 |
Low | 177.06 | 273.38 | 64.97 | 392.47 | 888.52 |
Last | 178.75 | 277.37 | 65.51 | 402.14 | 903.48 |
Change | -0.93 | +3.43 | +0.31 | +9.33 | +12.82 |
% Change | -0.52% | +1.25% | +0.48% | +2.38% | +1.44% |
Volume | 7,884,200 | 2,278,379 | 7,072,300 | 1,236,092 | 586,202 |
20-Day Average Volume | 1,302,050 | 2,240,759 | 7,425,765 | 998,480 | 476,140 |
Previous Close | 179.68 | 273.94 | 65.20 | 392.81 | 890.66 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 174.46 | 269.69 | 67.33 | 398.90 | 909.13 |
20-Day Raw Stochastic | 84.01% | 87.11% | 13.02% | 51.46% | 32.49% |
20-Day Relative Strength | 70.12% | 52.79% | 32.15% | 47.81% | 42.63% |
Weighted Alpha | +57.78 | +14.56 | -21.43 | +14.78 | +17.16 |
Today's Opinion | 100% Buy | 24% Sell | 100% Sell | 8% Buy | 8% Buy |
Previous Opinion | 100% Buy | 40% Sell | 100% Sell | 24% Sell | 8% Buy |
Last Month's Opinion | 88% Buy | 8% Sell | 88% Sell | 40% Buy | 64% Buy |
Performance | |||||
5-Days | |||||
%Chg | +3.26% since 11/12/21 | +1.60% since 04/24/24 | -2.34% since 04/24/24 | +0.34% since 04/24/24 | -0.34% since 04/24/24 |
Low | 173.17 on 11/16/21 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 |
High | 179.94 on 11/17/21 | 279.84 on 05/01/24 | 67.90 on 04/25/24 | 406.95 on 05/01/24 | 915.00 on 04/25/24 |
1-Month | |||||
%Chg | +2.88% since 10/19/21 | -2.00% since 04/01/24 | -10.11% since 04/01/24 | -4.36% since 04/01/24 | -6.79% since 04/01/24 |
Low | 172.25 on 10/20/21 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
High | 179.94 on 11/17/21 | 283.91 on 04/02/24 | 72.85 on 04/02/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 |
3-Month | |||||
%Chg | +48.97% since 08/19/21 | -14.54% since 02/01/24 | -16.18% since 02/01/24 | -7.31% since 02/01/24 | -5.67% since 02/01/24 |
Low | 120.20 on 08/20/21 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
High | 189.99 on 09/29/21 | 329.72 on 02/05/24 | 77.99 on 02/02/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 |
6-Month | |||||
%Chg | +44.53% since 05/19/21 | +6.34% since 11/01/23 | -18.31% since 11/01/23 | +8.88% since 11/01/23 | +14.18% since 11/01/23 |
Low | 113.49 on 07/15/21 | 260.52 on 11/21/23 | 64.63 on 04/26/24 | 341.90 on 11/16/23 | 783.57 on 11/10/23 |
High | 189.99 on 09/29/21 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
Key Statistics | |||||
Market Capitalization, $K | 10,931,634 | 146,934,848 | 81,179,024 | 101,525,288 | 97,760,624 |
Shares Outstanding, K | 61,156 | 536,376 | 1,245,077 | 258,459 | 109,762 |
Annual Sales | 92,520,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
Annual Net Income | -166,030,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
Last Quarter Sales | 34,200,000 | 8,196,000,000 | 6,686,000,000 | 2,517,700,000 | 3,434,300,000 |
Last Quarter Net Income | -70,470,000 | 767,000,000 | -4,170,000,000 | 968,800,000 | 1,159,600,000 |
60-Month Beta | 0.13 | 0.58 | 0.19 | 0.35 | 0.11 |
Per-Share Information | |||||
Most Recent Earnings | -1.16 on 11/04/21 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
Latest Earnings Date | 11/04/21 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 14.82 | 16.36 | 29.48 | 23.75 |